IP Library Assignment 017512/0414
Patent Assignment
Reel/Frame 017512/0414

Assignment of Assignor's Interest

Recorded: 2006-04-21 Pages: 6
Assignors
LOIBNER, HANS
Executed: 2005-02-14
PUTZ, THOMAS
Executed: 2005-02-14
HIMMLER, GOTTFRIED
Executed: 2005-02-15
FREISSMUTH, MICHAEL
Executed: 2005-02-22
KLINGER, MARKUS
Executed: 2005-02-22
FARHAN, HESSO
Executed: 2005-02-22
Assignee
IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
BRUNNER STRASSE 69, OBJEKT 3, VIENNA, A-1230, AUSTRIA
Covered Property (1)
Use of a Preparation Based on an Antibody Directed Against a Tumor-Associated Glycosylation
Patent: 7,527,789 →
Application: 10/519,323 →
Publication: US 2005/0226880
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Certificate of Appointment Jun 4, 2010
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: HOCHEGGER, HERBERT, DR.
Reel/Frame 024483/0817 →
Assignment of Assignor's Interest Jun 4, 2010
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: GREENOVATION BIOTECH GMBH; VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
Reel/Frame 024483/0823 →
Assignment of Assignor's Interest Jun 4, 2010
From: VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
To: MERIDIAN BIOPHARMACEUTICALS GMBH
Reel/Frame 024483/0831 →
Change of Name Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
Reel/Frame 025672/0254 →